![Maja Suter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Maja Suter
Nessuna posizione attualmente
Profilo
Ms. Maja Suter is a Director at CELLnTec Advanced Cell Systems AG.
She is on the Board of Directors at CELLnTec Advanced Cell Systems AG.
Precedenti posizioni note di Maja Suter
Società | Posizione | Fine |
---|---|---|
CELLnTec Advanced Cell Systems AG
![]() CELLnTec Advanced Cell Systems AG Pharmaceuticals: GenericHealth Technology CELLnTec Advanced Cell Systems AG develops methods for the cultivation of epithelial cells. It offers progenitor cell targeted (PCT) media for the isolation and retention of undifferentiated cells, and non-PCT media for differentiation in 2D or 3D culture; and primary human and long-term animal cells. The firm also offers various products for the culture of primary epidermal keratinocytes, airway epithelium cells, primary epithelial cells from human and a range of animal species, primary corneal and limbal epithelial cells from human and mouse, primary fibroblasts from human and a range of animal species, primary prostate epithelial cells from human and a range of animal species, and other products. The company was founded by Peter Girling, Maja Suter and Eliane Müller in 2002 and is headquartered in Bern, Switzerland. | Fondatore | - |
Esperienze
Posizioni ricoperte
Società collegate
Aziende private | 1 |
---|---|
CELLnTec Advanced Cell Systems AG
![]() CELLnTec Advanced Cell Systems AG Pharmaceuticals: GenericHealth Technology CELLnTec Advanced Cell Systems AG develops methods for the cultivation of epithelial cells. It offers progenitor cell targeted (PCT) media for the isolation and retention of undifferentiated cells, and non-PCT media for differentiation in 2D or 3D culture; and primary human and long-term animal cells. The firm also offers various products for the culture of primary epidermal keratinocytes, airway epithelium cells, primary epithelial cells from human and a range of animal species, primary corneal and limbal epithelial cells from human and mouse, primary fibroblasts from human and a range of animal species, primary prostate epithelial cells from human and a range of animal species, and other products. The company was founded by Peter Girling, Maja Suter and Eliane Müller in 2002 and is headquartered in Bern, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Maja Suter